Omega Therapeutics Inc Investor Relations Material
Latest events
Study Update
Omega Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Omega Therapeutics Inc
Access all reports
Omega Therapeutics Inc. is a clinical-stage biotechnology company focused on developing a new class of programmable epigenomic mRNA medicines. The company's OMEGA platform enables precise control of gene expression without altering native nucleic acid sequences, aiming to address the root causes of various diseases. Omega's therapeutic candidates target a range of conditions, including oncology, regenerative medicine, and multigenic and monogenic diseases. Founded in 2017 by Flagship Pioneering, Omega Therapeutics is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
OMGA
Country
🇺🇸 United States